Skip to main content
OpenTrials

Clinical trial condition

Iris Melanoma

Explore clinical trials studying Iris Melanoma. Study availability and eligibility vary by location and protocol.

13 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Iris Melanoma trial results

Completed

Sargramostim, Vaccine Therapy, or Sargramostim and Vaccine Therapy in Preventing Disease Recurrence in Patients With Melanoma That Has Been Removed By Surgery

NCT01989572

Conditions
Eye Diseases, Eye Neoplasms, Iris Melanoma, +34 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Mobile Infirmary Medical Center Mobile, Alabama, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
View all 148 locations
View Trial Details
Completed

Vorinostat in Treating Patients With Metastatic or Unresectable Melanoma

NCT00121225

Conditions
Ciliary Body and Choroid Melanoma, Medium/Large Size, Extraocular Extension Melanoma, Eye Diseases, +20 more
Locations
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
  • Fox Chase Cancer Center Rockledge, Pennsylvania, United States
  • Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada
  • Princess Margaret Hospital Phase 2 Consortium Toronto, Ontario, Canada
View Trial Details
Completed

Temozolomide or Selumetinib in Treating Patients With Metastatic Melanoma of the Eye

NCT01143402

Conditions
Eye Diseases, Eye Neoplasms, Iris Melanoma, +17 more
Locations
  • University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora, Colorado, United States
  • Mount Sinai Medical Center Miami Beach, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
View all 33 locations
View Trial Details

Related conditions